Grindeks AS Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Grindeks AS

Grindeks AS | Mutual Funds

Mutual Funds that own Grindeks AS

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

AST Parametric Emerging Markets Equity Portfolio

52,160

0.54%

0.1%

03/29/2018

Eaton Vance Parametric Emerging Markets Fund

42,000

0.44%

0.02%

06/30/2018

Finasta Baltic Fund

20,600

0.22%

-7,400

3.17%

06/30/2017

Eaton Vance Parametric Tax Managed Emerging Markets Fund

12,000

0.13%

06/30/2018

Eaton Vance Intl. (Ireland) - Parametric Emerging Markets Fund

11,842

0.12%

0.02%

06/29/2018

Trigon Baltic Fund

4,600

0.05%

4,600

2.17%

06/30/2017

OMX Baltic Benchmark Fund

4,346

0.05%

1.24%

06/30/2017

LHV World Equities Fund

-2,500

12/31/2016

About Grindeks AS

View Profile

Address	Krustpils iela 53 Riga RA LV Latvia
Employees	-
Website	http://www.grindeks.lv
Updated	07/08/2019
Grindeks PJSC is a pharmaceutical company, which engages in the research, development, manufacture, and sale of original products, generics, and active pharmaceutical products. Its services include registration, contract manufacturing, and analytical. The company was founded in 1946 and is headquartered in Riga, Latvia.